Pick of the Week: Biocon - 19th September, 2026
Biocon Limited is one of India's premier biopharmaceutical companies, offering high-quality biosimilars, complex small molecule APIs, and generic...
100 Views
Pharma and Healthcare - Q2FY27E: Result Preview
We expect pharmaceutical companies under our coverage to deliver a subdued yet positive performance in Q2FY27, with aggregate revenue rising 7.0%...
90 Views
Biocon Ltd - Blip in Biosimilars; Structural Story Intact
Generics & Biosimilars Driving Growth, CRDMO Drags: Biocon’s Q3FY26 top line performance was a miss versus expectations, with reported revenue of...
148 Views
Pick of the Week: Biocon - 29th November, 2025
The company has developed and commercialized novel biologics, biosimilars, complex small molecule APIs in India and key global markets, and generic...
226 Views
Biocon Ltd - Resilient Momentum in Biosimilars Driving Growth
Biocon reported an in-line performance for Q2FY26, with revenue rising 19.6% YoY and 9% QoQ to Rs 4,296 Cr, driven by strong traction in...
287 Views